These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29525818)

  • 1. Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.
    Warraich HJ; Salami JA; Khera R; Valero-Elizondo J; Okunrintemi V; Nasir K
    JAMA Intern Med; 2018 May; 178(5):719-721. PubMed ID: 29525818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
    JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.
    Lin SY; Baumann K; Zhou C; Zhou W; Cuellar AE; Xue H
    JAMA Netw Open; 2021 Nov; 4(11):e2135371. PubMed ID: 34807258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of compliance and cost effectiveness between brand-name statins and generic statins].
    He L; Du X; Wang WH; Ma CS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1900-1904. PubMed ID: 33297658
    [No Abstract]   [Full Text] [Related]  

  • 5. Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.
    Mortensen MB; Falk E; Schmidt M
    Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28698192
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic atorvastatin and health care costs.
    Jackevicius CA; Chou MM; Ross JS; Shah ND; Krumholz HM
    N Engl J Med; 2012 Jan; 366(3):201-4. PubMed ID: 22149736
    [No Abstract]   [Full Text] [Related]  

  • 8. Zero copayment for generic statins could save billions.
    Manag Care; 2013 Mar; 22(3):44. PubMed ID: 23610806
    [No Abstract]   [Full Text] [Related]  

  • 9. Encouraging generic use can yield significant savings.
    Zimmerman C
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of manufacturer coupon use in the statin market.
    Daugherty JB; Maciejewski ML; Farley JF
    J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.
    Li P; Schwartz JS; Doshi JA
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27836822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Price difference as a predictor of the selection between brand name and generic statins in Japan.
    Takizawa O; Urushihara H; Tanaka S; Kawakami K
    Health Policy; 2015 May; 119(5):612-9. PubMed ID: 25697888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic atorvastatin and rosuvastatin in the South Korean market: time of introduction in relation to manufacturer characteristics.
    Son KB
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):541-548. PubMed ID: 31483158
    [No Abstract]   [Full Text] [Related]  

  • 14. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
    Hoadley JF; Merrell K; Hargrave E; Summer L
    Health Aff (Millwood); 2012 Oct; 31(10):2266-75. PubMed ID: 23048108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
    Salami JA; Warraich H; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Lloyd-Jones D; Nasir K
    JAMA Cardiol; 2017 Jan; 2(1):56-65. PubMed ID: 27842171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Save green, go generic: be prepared to answer the $4 question.
    Hansen D
    S D Med; 2009 Nov; 62(11):436-7. PubMed ID: 20128174
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for patients. Comparative effectiveness of generic and brand-name statins on patient outcomes.
    Ann Intern Med; 2014 Sep; 161(6):I-30. PubMed ID: 25222407
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017.
    Rome BN; Lee CC; Gagne JJ; Kesselheim AS
    Value Health; 2021 Jun; 24(6):804-811. PubMed ID: 34119078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs.
    Gastala NM; Wingrove P; Gaglioti A; Petterson S; Bazemore A
    Health Aff (Millwood); 2016 Jul; 35(7):1237-40. PubMed ID: 27385239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.